Pulmonary Langerhans cell histiocytosis presenting as an uncommon mass in the lung: A rare case report and literature review

Abstract

Key Clinical Message A comprehensive diagnostic approach, including immunohistochemistry, is crucial for confirming pulmonary Langerhans cell histiocytosis in adults. Individualized treatment with dynamically adjusted chemotherapy based on therapeutic response leads to significant absorption of lesions and symptom alleviation. Regular follow‐up and timely treatment adjustments according to the patient's condition are essential in managing this rare disease.

Keywords

• chemotherapy
• histiocytosis
• Langerhans cells
• pulmonary Langerhans cell histiocytosis